🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine

RecruitingPhase 4Ages 18 Years - anyAllThe University of Texas Health Science Center, Ho…
NCT06029049 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, and movement of limbs and coughing during tracheal intubation in order to assess intubation conditions, to compare efficiency and success rate of tracheal intubation between two induction agents and to determine the rate of patient awareness during induction and post-operative recall of paralysis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * BMI \> 30kg/m2 or Mallampati class III or IV. * Requiring general anesthesia and endotracheal intubation Exclusion Criteria: * Acute and chronic respiratory disorders, including Chronic obstructive pulmonary disease(COPD) and asthma. * The American Society of Anesthesiologists (ASA) physical status classification \> III. * Patients requiring awake intubation. * Pregnant women. * Untreated ischemic heart disease. * Patients requiring an induction dose of propofol \< 1 mg/kg. * Allergy to propofol, rocuronium, succinylcholine, or sugammadex. * Patients with renal failure and unknown potassium (K+) level, or patients with K+ level \> 5.0 * Personal history of malignant hyperthermia (MH), or family history of MH * Patients with suspected or diagnosed neuromuscular disease, patients with burn injuries
💊

What it tests

  • Modified Time Principle Induction (MTPI) with rocuronium
  • RSI succinylcholine
📍

Where

1 site
The University of Texas Health Science Center at Houston
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy